Skip to content

Proactive Community Case Management (Pro-CCM) in Rural Madagascar

Randomized Cluster Trial to Measure the Effectiveness of Home Care in Hyperendemic Rural Areas in Madagascar

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05223933
Acronym
Pro-CCM
Enrollment
1000
Registered
2022-02-04
Start date
2016-12-12
Completion date
2018-12-29
Last updated
2022-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Case Management, Malaria

Keywords

Malaria, Rural area, Community health workers

Brief summary

The trial took place in a rural area hyper endemic for malaria, the hypothesis of which was that active detection and treatment of malaria in the population (all ages combined) in the event of a positive test could reduce the prevalence of malaria in the region. zoned. It was a two-armed, randomized, cluster-based community intervention trial: * one arm with home treatment of malaria for the duration of the study for patients with a positive result in the rapid diagnostic test for malaria. * a control arm with the usual malaria management procedures (ie consultation with community workers or the nearest health centers in the event of fever or suspected signs of malaria). Before the start of monitoring, an initial survey (Baseline) was carried out in the fokontany (villages / cluster) included in the 2 arms, in order to determine the prevalence of malaria. Then, in the intervention arm, screening for malaria by RDT every 2 weeks in subjects with a suspected malaria case (fever or notion of fever in the 2 days preceding the visit) and treatment with Artesunate-amodiaquine (ACT) for patients with a positive RDT. At the end of the follow-up period, a final survey (Endline), based on the same questionnaires as during the Baseline, was carried out in the 2 villages of the 2 arms. As a secondary objective, a study on anemia in women aged between 15 and 49 years was also carried out during the baseline and endline periods in order to compare the prevalence between the 2 periods

Detailed description

This study aims to compare the prevalence of malaria in the rural community of Mananjary after the Malaria Home Care Program (PECADOM Plus). The study will take place in fokontany rural communes of the district of Mananjary. This district was chosen for the following reasons: * High prevalence of malaria in this area (31% in subjects with fever and attending medical consultation in the CSB included in the sentinel IPM fever site) * presence of Peace Corps Volunteers (PCV) in this district. Mananjary District is situated in southeastern Madagascar, located in the central part of the Vatovavy Fitovinany Region, in the province of Fianarantsoa. It is located at 21°13'52 South and 48°20'31 East. The district is composed of one urban commune and 28 rural communes. After obtaining the agreement of the ethics committee for the realization of the study, the coordinator or the assistant coordinator of the project will make courtesy visits to all administrative and health officials in the Vatovavy Fitovinany and Mananjary District (Regional Directorate, District Chief ...).A random draw of fokontany meeting the inclusion criteria will be carried out later, to identify the distribution of fokontany in the intervention arm and control arm in the project. In addition to the 22 fokontany required, a draw of 8 reserve fokontany will be made (4 for each arm). A courtesy visit will be conducted in the fokontany raffled. The coordinator will check the number of inhabitants in these fokontany with the information gathered at the time of the preparation of the protocol (projection of the population according to the data of INSTAT, information from the Medical Inspector of Mananjary). If the fokontany will not be eligible, the reserve fokontany will replace them in the study.

Interventions

CHWs in the intervention arm conducted door-to-door fever screening for all inhabitants of all consenting households in their catchment area every fortnight. All individuals with temperature ≥ 37.5°C or history of self-reported fever in the previous two weeks were tested with an RDT; positive individuals who were not pregnant and did not have signs of severe disease were treated with artesunate-amodiaquine according to treatment guidelines. Individuals identified as requiring a referral during Pro-CCM visits were assisted with transfer to the healthcare center, with transportation handled by the project staff.

Sponsors

Peace Corps
CollaboratorOTHER
National Malaria Control Programme, Madagascar
CollaboratorOTHER_GOV
United States Agency for International Development (USAID)
CollaboratorFED
Institut Pasteur de Madagascar
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

The study was a two-arm cluster randomized community intervention trial, with 11 fokontany in the intervention arm implementing malaria pro-CCM and 11 in the control arm. In both arms, CHWs provided passive integrative community case management (iCCM) among children under five per usual standard of care, including diagnosis with RDT for febrile illness, treatment with artesunate-amodiaquine according to RDT results, along with diagnosis and management of acute respiratory infections and diarrhea, and referral to a higher level of care if indicated. Oral rehydration salts, antibiotics were distributed to CHWs in the intervention arm to reinforce the iCCM activities already implemented.

Eligibility

Sex/Gender
ALL
Age
2 Months to No maximum
Healthy volunteers
No

Inclusion criteria

* Inclusion criteria in community: * Fokontany in rural communes of Mananjary district (fokontany level of safety, accessibility by the study teams, and phone network availability was assessed). * Agreement of the chief of Fokontany for the participation of his fokontany in the study * Fokontany with at least 1,000 inhabitants * Individual inclusion criteria: * Resident in the relevant areas during the study period and consenting to participate

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
The primary endpoint of the study was the change in the prevalence of malaria RDT positivity in the intervention versus control fokontany.an average of 1 yearDifference in differences (DiD) approach comparing baseline to endline is used to compare the prevalence of malaria RDT positivity in the 2 arms

Secondary

MeasureTime frameDescription
percent of households gave consentThe event was assessed up to 30 weeks (15 biweekly visits).percent of households that were visited every two weeks and gave consent for the screening during each visit
Fever incidenceThe event was assessed up to 30 weeks (15 biweekly visits).percent of fever cases out of all individuals screened during each visit
Malaria incidenceThe event was assessed up to 30 weeks (15 biweekly visits).percent of persons with positive RDT and fever cases out of all individuals screened during each visit
percent of households visited every two weeksThe event was assessed up to 30 weeks (15 biweekly visits).percent of households visited every two weeks out of the number of the households registered in initial census
RDT-positive persons treated with an ACTThe event was assessed up to 30 weeks (15 biweekly visits).percent of RDT-positive persons treated with an ACT during each visit
The change in the prevalence of anemia in women aged between 15 and 49 years old in the intervention versus control fokontanyan average of 1 yearDifference in differences (DiD) approach comparing baseline to endline is used to compare the prevalence of anemia in the 2 arms
fever cases with RDT performedThe event was assessed up to 30 weeks (15 biweekly visits).percent of fever cases with RDT performed

Countries

Madagascar

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026